Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA delays decision on Heron's twice-rejected nausea drug
FDA delays decision on Heron's twice-rejected nausea drug
FDA delays decision on Heron's twice-rejected nausea drug
Submitted by
admin
on January 16, 2016 - 11:25am
Source:
Fierce Biotech
News Tags:
FDA
Heron Therapeutics
Sustol
chemotherapy-induced nausea and vomiting
Headline:
FDA delays decision on Heron's twice-rejected nausea drug
Do Not Allow Advertisers to Use My Personal information
